6th International Conference: Genomic Medicine Implementation in Low Resource Settings

第六届国际会议：资源匮乏环境下的基因组医学实施

• 批准号: 10318318
• 负责人: GABRIELA REPETTO
• 金额: $ 3.64万
• 依托单位: GLOBAL GENOMIC MEDICINE COLLABORATIVE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-21 至 2022-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10318318
• 关键词: Academia; Achievement; Advocate; Affect; COVID-19 pandemic; Caring; Chile; Clinical Trials; Collaborations; Communities; Country; Development; Diagnosis; Discipline; Disease; Education; Elements; Epidemiologist; Event; Family; Fostering; Future; Genomic medicine; Genomics; Geography; Goals; Government; Health; Health Personnel; Health system; Healthcare; Human; Hybrids; Income; Individual; Industry; International; Investments; Latin America; Lead; Leadership; Location; Malignant Neoplasms; Mentors; Mentorship; Outcome; Participant; Patients; Persons; Pharmacogenomics; Physicians; Play; Policies; Policy Maker; Population Heterogeneity; Prevention; Privatization; Probability; Rare Diseases; Recording of previous events; Research; Research Personnel; Resources; Risk; Role; Scientist; System; Time; Training; Travel; Uncertainty; Underrepresented Populations; United States; Work; base; career; career development; clinical application; cost; demographics; evidence based guidelines; health care availability; health care delivery; implementation science; improved; meetings; member; outreach; patient population; population health; posters; programs; success; symposium; therapeutic development; virtual; working group

Abstract The Global Genomics Medicine Collaborative (G2MC) requests support for its 6th International Conference: Genomic Medicine Implementation in Low Resource Settings, organized by Drs. Geoffrey S. Ginsburg, Gabriela Repetto and Bruce Korf. The event will be held on September 29 - October 1, 2021 in Santiago, Chile. G2MC is a not-for-profit organization based in the United States with the goal of bringing together the global community to enable the implementation of genomic medicine to improve individual and population health. Many nations are investing in large-scale national genomic medicine programs. To maximize the value of this investment, we propose this gathering as a means to ‘de-silo’ these efforts and bring them together to inform implementation into healthcare delivery systems across diverse populations, demographics, and economies. To optimize the probability of success for implementing genomics into health care is it necessary to bring the leaders at the forefront of genomic medicine together in a forum conducive to impactful conversations and dialogues. While genomic medicine offers major opportunities for prevention, diagnosis, and treatment of disease, there is a significant risk that it will exacerbate disparities in access to healthcare. This is true in high-income countries such as the United States but is even more a concern in low resource settings (LRS). G2MC has selected the event location to enable engagement with regional attendees from Latin America, a traditionally underrepresented group in genomic medicine. The conference agenda will facilitate a deeper understanding of best practices from subject matter experts that can be applied to genomic medicine and advancement of G2MC’s implementation Flagship Projects. The conference will also provide a unique opportunity to mentor Young Investigators (YIs) from lower- and middle-resourced countries in Latin America and beyond by established G2MC investigators and high-profile speakers from around the world with expertise in genomic medicine. Given the current COVID-19 pandemic, this meeting is planned as a hybrid in-person and virtual event. G2MC will encourage YIs to attend in person, if possible, so as to increase their visibility, and highlight their achievements. An explicit goal of this meeting is to advance the careers of YIs through their interaction with G2MC members/investigators through mentorship, networking, dissemination of their research. YIs will also engage with G2MC Flagship Projects and working groups, leading to further opportunities for collaboration. The 6th International G2MC Conference is unique in emphasizing implementation through outreach with YIs as well as speaker and attendee representation from LRS. The agenda objectives emphasize solutions to implementation roadblocks by engaging with a truly global group of presenters and attendees to enable the successful implementation of genomic medicine around the world.

摘要 全球基因组医学合作组织(G2MC)请求支持其第六届国际会议： 低资源环境下的基因组医学实施，由Geoffrey S.Ginsburg博士组织， 加布里埃拉·雷佩托和布鲁斯·科夫。该活动将于2021年9月29日至10月1日在圣地亚哥举行， 智利。G2MC是一个总部设在美国的非营利性组织，其目标是将 全球社区支持实施基因组医学，以改善个人和人口 健康。许多国家都在投资大规模的国家基因组医学项目。实现价值最大化 在这项投资中，我们建议将这次会议作为一种手段，以消除这些努力的影响，并将它们聚集在一起 在不同的人群、人口统计和 经济。为了优化将基因组学应用于医疗保健的成功概率，有必要 将基因组医学前沿的领导者聚集在一个有利于产生影响的论坛上 对话和对话。虽然基因组医学为预防、诊断和治疗提供了重大机遇 在疾病治疗方面，有一个很大的风险，那就是它将加剧获得医疗保健方面的差距。这是 在美国等高收入国家确实如此，但在资源匮乏的情况下更令人担忧 (LRS)。G2MC已经选择了活动地点，以便与来自拉丁语的地区与会者互动 美国，一个传统上在基因组医学中代表性不足的群体。会议议程将促进 更深入地了解可应用于基因组医学的主题专家的最佳实践 和推进G2MC的实施旗舰项目。大会还将提供一个独特的 指导拉丁美洲中低资源国家青年调查人员(YI)的机会 以及来自世界各地的资深G2MC调查人员和具有专业知识的知名演讲者 在基因组医学领域。鉴于当前新冠肺炎的大流行，此次会议计划以面对面混合方式进行 和虚拟活动。G2MC将在可能的情况下鼓励YI亲自出席，以提高他们的知名度，以及 突出他们的成就。这次会议的一个明确目标是通过他们的 通过指导、建立网络、传播他们的研究成果，与G2MC成员/研究人员互动。 YIS还将与G2MC旗舰项目和工作组接触，带来更多机会 协作。第六届国际G2MC会议通过以下方式强调执行是独一无二的 与YIS的接触以及LRS的演讲者和与会者代表。议程目标 通过与真正全球化的演讲者小组接触，强调解决实施障碍的方案，并 与会者支持在世界各地成功实施基因组医学。